Evidence map›Paper›PMID 36551685›Full record

ArticleCancers2022

Tumoricidal, Temozolomide- and Radiation-Sensitizing Effects of K

Nicolai Stransky, Katrin Ganser, Ulrike Naumann, Stephan M Huber, Peter Ruth

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nicolai StranskyDepartment of Radiation Oncology, University of Tübingen, 72076 Tübingen, Germany.ORCID 0000-0002-0872-5220
Katrin GanserDepartment of Radiation Oncology, University of Tübingen, 72076 Tübingen, Germany.
Ulrike NaumannMolecular Neurooncology, Hertie Institute for Clinical Brain Research and Center Neurology, University of Tübingen, 72076 Tübingen, Germany.ORCID 0000-0003-3555-5703
Stephan M HuberDepartment of Radiation Oncology, University of Tübingen, 72076 Tübingen, Germany.
Peter RuthDepartment of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, 72076 Tübingen, Germany.
University of Tübingen · DEHertie Institute for Clinical Brain Research · DE

Funding

German Cancer Aid 70112872, 70113144
6 · The paper itself

Abstract

Reportedly, the intermediate-conductance Ca

Indexed as

colony formation assayglioma stem cellsionizing radiationlimited dilution assaytemozolomideTRAM-34

Identifiers

PMID36551685
PMCPMC9776522
OpenAlexW4311687976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.